Stock Chart

ATAI

$7.35 +0.82%
Score: 44.2 HOLD
Pro
Screener
Vol: 0.71x (vs SPY: 0.7x | vs QQQ: 0.7x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 10, 2026
Rising Channel Bearish scenario quality 76/100
Measured-move target $7.29 (-0.9%)
Lower rail breaks first 80% of the time (n=1,744) — a trend-exit tell, not a crash call
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About ATAI - ATAI Life Sciences N.V. Common Shares

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

Key Statistics

Market Cap $3B

More ATAI Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This ATAI stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ATAI's price movements with trendlines, gamma walls, and key support/resistance levels.